Aura Biosciences Presents Updated Phase 1b/2 Clinical Data for AU-011 at the American Academy of Ophthalmology 2018 Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aura Biosciences today announced that updated data from its Phase 1b/2 trial evaluating the safety and efficacy of light-activated AU-011 was highlighted in an oral presentation at AAO 2018.

Full Story →